REDDITCH, England, March 24, 2023 /PRNewswire/ -- Concentric AB published today the Annual Report for 2022 on www.concentricab.com and is available in both Swedish and English. The Swedish Annual Report is also available in European Single Electronic Format (ESEF).
This disclosure contains information that Concentric AB is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, at 8.00 CET on 24 March 2023
For additional information please contact Marcus Whitehouse, telephone +44-121-445 6545
Fast Guard Service, a leading provider of security guard services, has released "The Ultimate Guide to Choosing the Best Fire Watch Service." This guide aims to assist business owners and property managers in making informed decisions when hiring...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of its novel drug candidate...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
